Patient Pathfinder: Clinical Trials
Clinical Trials for Myelodysplastic Syndrome
Every life-saving or life-extending treatment that’s available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myelodysplastic Syndrome (MDS), and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 166 active Myelodysplastic Syndrome trials
Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML
Study Type: Interventional Phase 1
Shwachman Diamond Syndrome Registry and Study
Study Type: Observational
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
Study Type: Interventional Phase 1
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
Study Type: Interventional Phase 3
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
Study Type: Interventional Phase 2
Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients
Study Type: Interventional Phase 1
Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes
Study Type: Interventional Phase 1
Allogeneic Hematopoietic Stem Cell Transplantation With JSP191-Based Conditioning in Participants With GATA2 Deficiency
Study Type: Interventional Phase 2
There are 166 active Myelodysplastic Syndrome trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now